XCR Diagnostics Overview

  • Founded
  • 2015

  • Status
  • Private

  • Employees
  • 11

  • Latest Deal Type
  • M&A

  • (Cancelled)

XCR Diagnostics General Information


Developer of diagnostic devices intended to offer molecular diagnostic near-patient testing products. The company offers a portable nucleic acid testing system which is used with the Sample Delivery System to perform on-demand testing providing actionable results in a few minutes, thereby allowing clinicians to provide clinical decisions and treatment at the patient's initial visit.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Primary Office
  • 4750 Wiley Post Way
  • Suite 110
  • Salt Lake City, UT 84116
  • United States
+1 (800) 000-0000

XCR Diagnostics Timeline

Financing Round

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

XCR Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 29-Jul-2020 Cancelled Generating Revenue
3. Debt - PPP 01-May-2020 00.00 Completed Generating Revenue
2. Seed Round 11-Oct-2019 $1.8M $4.3M Completed Generating Revenue
1. Seed Round 22-Nov-2016 $2.5M $2.5M Completed Generating Revenue
To view XCR Diagnostics’s complete valuation and funding history, request access »

XCR Diagnostics Patents

XCR Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10669574-B2 Dna amplification technology Active 10-Jul-2014 0000000000
EP-3055430-A2 Multiplex probes Granted 09-Oct-2013 000000000
US-20200172958-A1 Multiplex probes Pending 09-Oct-2013 000000000
US-10370707-B2 Multiplex probes Active 09-Oct-2013 000000000
US-20150099659-A1 Multiplex probes Granted 09-Oct-2013 C12Q1/686
To view XCR Diagnostics’s complete patent history, request access »

XCR Diagnostics Executive Team (2)

Name Title Board Seat Contact Info
Mark Powelson Chief Executive Officer, President and Board Member
Brian Caplin Ph.D Chief Scientific Officer & Board Member
To view XCR Diagnostics’s complete executive team members history, request access »

XCR Diagnostics Board Members (8)

Name Representing Role Since
Brian Caplin Ph.D XCR Diagnostics Chief Scientific Officer & Board Member 000 0000
Bruce Chafin Self Board Member 000 0000
Chuck Morrison Self Board Member 000 0000
Linda Merrill XCR Diagnostics Board Member 000 0000
Mark Bagnall Self Chairman 000 0000
You’re viewing 5 of 8 board members. Get the full list »

XCR Diagnostics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial